{
  "disease_name": "Mitochondrial neurogastrointestinal encephalomyopathy",
  "orpha_code": "298",
  "drugs": [
    {
      "name": "Adeno-associated virus vector serotype 8 containing the human TYMP gene (CpG-depleted)",
      "substance_url": "/en/drug/substance/686836?name=298&mode=orpha&region=&status=all",
      "substance_id": "686836",
      "regulatory_url": "/en/drug/regulatory/686924?name=298&mode=orpha&region=",
      "regulatory_id": "686924",
      "orpha_substance_code": "ORPHA:298",
      "details": [
        "Adeno-associated virus vector serotype 8 containing the human TYMP gene (CpG-depleted)(Medicinal product                        - 25/07/2024)Disease(s) concernedORPHA:298 Mitochondrial neurogastrointestinal encephalomyopathy",
        "Adeno-associated virus vector serotype 8 containing the human TYMP gene (CpG-depleted)(Medicinal product                        - 25/07/2024)",
        "(Medicinal product                        - 25/07/2024)",
        "Disease(s) concernedORPHA:298 Mitochondrial neurogastrointestinal encephalomyopathy",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/686836?name=298&mode=orpha&region=&status=all",
          "text": "Adeno-associated virus vector serotype 8 containing the human TYMP gene (CpG-depleted)",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/298",
          "text": "ORPHA:298 Mitochondrial neurogastrointestinal encephalomyopathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/686924?name=298&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Vector based on an adeno-associated virus serotype 2 backbone, pseudo-serotyped with a type 8 capsid, which carries the coding sequence of the human TYMP gene under the control of the human thyroxine binding globulin promoter",
      "substance_url": "/en/drug/substance/406542?name=298&mode=orpha&region=&status=all",
      "substance_id": "406542",
      "regulatory_url": "/en/drug/regulatory/412236?name=298&mode=orpha&region=",
      "regulatory_id": "412236",
      "orpha_substance_code": "ORPHA:298",
      "details": [
        "Vector based on an adeno-associated virus serotype 2 backbone, pseudo-serotyped with a type 8 capsid, which carries the coding sequence of the human TYMP gene under the control of the human thyroxine binding globulin promoter(Medicinal product                        - 22/08/2014)Disease(s) concernedORPHA:298 Mitochondrial neurogastrointestinal encephalomyopathy",
        "Vector based on an adeno-associated virus serotype 2 backbone, pseudo-serotyped with a type 8 capsid, which carries the coding sequence of the human TYMP gene under the control of the human thyroxine binding globulin promoter(Medicinal product                        - 22/08/2014)",
        "(Medicinal product                        - 22/08/2014)",
        "Disease(s) concernedORPHA:298 Mitochondrial neurogastrointestinal encephalomyopathy",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/406542?name=298&mode=orpha&region=&status=all",
          "text": "Vector based on an adeno-associated virus serotype 2 backbone, pseudo-serotyped with a type 8 capsid, which carries the coding sequence of the human TYMP gene under the control of the human thyroxine binding globulin promoter",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/298",
          "text": "ORPHA:298 Mitochondrial neurogastrointestinal encephalomyopathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/412236?name=298&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Recombinant thymidine phosphorylase encapsulated in autologous erythrocytes",
      "substance_url": "/en/drug/substance/252239?name=298&mode=orpha&region=&status=all",
      "substance_id": "252239",
      "regulatory_url": "/en/drug/regulatory/275142?name=298&mode=orpha&region=",
      "regulatory_id": "275142",
      "orpha_substance_code": "ORPHA:298",
      "details": [
        "Recombinant thymidine phosphorylase encapsulated in autologous erythrocytes(Medicinal product                        - 15/04/2011)Disease(s) concernedORPHA:298 Mitochondrial neurogastrointestinal encephalomyopathy",
        "Recombinant thymidine phosphorylase encapsulated in autologous erythrocytes(Medicinal product                        - 15/04/2011)",
        "(Medicinal product                        - 15/04/2011)",
        "Disease(s) concernedORPHA:298 Mitochondrial neurogastrointestinal encephalomyopathy",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/252239?name=298&mode=orpha&region=&status=all",
          "text": "Recombinant thymidine phosphorylase encapsulated in autologous erythrocytes",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/298",
          "text": "ORPHA:298 Mitochondrial neurogastrointestinal encephalomyopathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/275142?name=298&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Adenoassociated virus vector (AAV) carrying a modified AAV serotype 2 backbone and coding sequence of human thymidine phosphorylase preceded by a human thyroxin-binding globulin promoter",
      "substance_url": "/en/drug/substance/412975?name=298&mode=orpha&region=&status=all",
      "substance_id": "412975",
      "regulatory_url": "/en/drug/regulatory/412976?name=298&mode=orpha&region=",
      "regulatory_id": "412976",
      "orpha_substance_code": "ORPHA:298",
      "details": [
        "Adenoassociated virus vector (AAV) carrying a modified AAV serotype 2 backbone and coding sequence of human thymidine phosphorylase preceded by a human thyroxin-binding globulin promoter(Medicinal product                        - 04/09/2014)Disease(s) concernedORPHA:298 Mitochondrial neurogastrointestinal encephalomyopathy",
        "Adenoassociated virus vector (AAV) carrying a modified AAV serotype 2 backbone and coding sequence of human thymidine phosphorylase preceded by a human thyroxin-binding globulin promoter(Medicinal product                        - 04/09/2014)",
        "(Medicinal product                        - 04/09/2014)",
        "Disease(s) concernedORPHA:298 Mitochondrial neurogastrointestinal encephalomyopathy",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/412975?name=298&mode=orpha&region=&status=all",
          "text": "Adenoassociated virus vector (AAV) carrying a modified AAV serotype 2 backbone and coding sequence of human thymidine phosphorylase preceded by a human thyroxin-binding globulin promoter",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/298",
          "text": "ORPHA:298 Mitochondrial neurogastrointestinal encephalomyopathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/412976?name=298&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "Recombinant thymidine phosphorylase encapsulated in autologous erythrocytes",
      "substance_url": "/en/drug/substance/252239?name=298&mode=orpha&region=&status=all",
      "substance_id": "252239",
      "regulatory_url": "/en/drug/regulatory/275145?name=298&mode=orpha&region=",
      "regulatory_id": "275145",
      "orpha_substance_code": "ORPHA:298",
      "details": [
        "Recombinant thymidine phosphorylase encapsulated in autologous erythrocytes(Medicinal product                        - 13/12/2010)Disease(s) concernedORPHA:298 Mitochondrial neurogastrointestinal encephalomyopathy",
        "Recombinant thymidine phosphorylase encapsulated in autologous erythrocytes(Medicinal product                        - 13/12/2010)",
        "(Medicinal product                        - 13/12/2010)",
        "Disease(s) concernedORPHA:298 Mitochondrial neurogastrointestinal encephalomyopathy",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/252239?name=298&mode=orpha&region=&status=all",
          "text": "Recombinant thymidine phosphorylase encapsulated in autologous erythrocytes",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/298",
          "text": "ORPHA:298 Mitochondrial neurogastrointestinal encephalomyopathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/275145?name=298&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "2-(1H-imidazol-1-yl)-N-(2-(2-methoxyethoxy) pyrimidin-5-yl)-6-(trifluoromethyl) pyrimidine-4-carboxamide",
      "substance_url": "/en/drug/substance/687120?name=298&mode=orpha&region=&status=all",
      "substance_id": "687120",
      "regulatory_url": "/en/drug/regulatory/687279?name=298&mode=orpha&region=",
      "regulatory_id": "687279",
      "orpha_substance_code": "ORPHA:206966",
      "details": [
        "2-(1H-imidazol-1-yl)-N-(2-(2-methoxyethoxy) pyrimidin-5-yl)-6-(trifluoromethyl) pyrimidine-4-carboxamide(Medicinal product                        - 26/08/2024)Disease(s) concernedORPHA:206966 Mitochondrial myopathy",
        "2-(1H-imidazol-1-yl)-N-(2-(2-methoxyethoxy) pyrimidin-5-yl)-6-(trifluoromethyl) pyrimidine-4-carboxamide(Medicinal product                        - 26/08/2024)",
        "(Medicinal product                        - 26/08/2024)",
        "Disease(s) concernedORPHA:206966 Mitochondrial myopathy",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/687120?name=298&mode=orpha&region=&status=all",
          "text": "2-(1H-imidazol-1-yl)-N-(2-(2-methoxyethoxy) pyrimidin-5-yl)-6-(trifluoromethyl) pyrimidine-4-carboxamide",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/206966",
          "text": "ORPHA:206966 Mitochondrial myopathy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/687279?name=298&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Methyl 4-{[2-(acetamino)ethyl]sulfanyl}-4-oxobutanoate",
      "substance_url": "/en/drug/substance/646586?name=298&mode=orpha&region=&status=all",
      "substance_id": "646586",
      "regulatory_url": "/en/drug/regulatory/646683?name=298&mode=orpha&region=",
      "regulatory_id": "646683",
      "orpha_substance_code": "ORPHA:68380",
      "details": [
        "Methyl 4-{[2-(acetamino)ethyl]sulfanyl}-4-oxobutanoate(Medicinal product                        - 14/04/2023)Disease(s) concernedORPHA:68380 Mitochondrial disease",
        "Methyl 4-{[2-(acetamino)ethyl]sulfanyl}-4-oxobutanoate(Medicinal product                        - 14/04/2023)",
        "(Medicinal product                        - 14/04/2023)",
        "Disease(s) concernedORPHA:68380 Mitochondrial disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/646586?name=298&mode=orpha&region=&status=all",
          "text": "Methyl 4-{[2-(acetamino)ethyl]sulfanyl}-4-oxobutanoate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/68380",
          "text": "ORPHA:68380 Mitochondrial disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/646683?name=298&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Zagociguat",
      "substance_url": "/en/drug/substance/644348?name=298&mode=orpha&region=&status=all",
      "substance_id": "644348",
      "regulatory_url": "/en/drug/regulatory/644353?name=298&mode=orpha&region=",
      "regulatory_id": "644353",
      "orpha_substance_code": "ORPHA:68380",
      "details": [
        "Zagociguat(Medicinal product                        - 23/03/2023)Disease(s) concernedORPHA:68380 Mitochondrial disease",
        "Zagociguat(Medicinal product                        - 23/03/2023)",
        "(Medicinal product                        - 23/03/2023)",
        "Disease(s) concernedORPHA:68380 Mitochondrial disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/644348?name=298&mode=orpha&region=&status=all",
          "text": "Zagociguat",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/68380",
          "text": "ORPHA:68380 Mitochondrial disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/644353?name=298&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Vatiquinone",
      "substance_url": "/en/drug/substance/285822?name=298&mode=orpha&region=&status=all",
      "substance_id": "285822",
      "regulatory_url": "/en/drug/regulatory/299940?name=298&mode=orpha&region=",
      "regulatory_id": "299940",
      "orpha_substance_code": "ORPHA:254827",
      "details": [
        "Vatiquinone(Medicinal product                        - 21/12/2010)Disease(s) concernedORPHA:223713 Mitochondrial oxidative phosphorylation disorderORPHA:254827 Mitochondrial membrane transport disorder",
        "Vatiquinone(Medicinal product                        - 21/12/2010)",
        "(Medicinal product                        - 21/12/2010)",
        "Disease(s) concernedORPHA:223713 Mitochondrial oxidative phosphorylation disorderORPHA:254827 Mitochondrial membrane transport disorder",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/285822?name=298&mode=orpha&region=&status=all",
          "text": "Vatiquinone",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/223713",
          "text": "ORPHA:223713 Mitochondrial oxidative phosphorylation disorder",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/254827",
          "text": "ORPHA:254827 Mitochondrial membrane transport disorder",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/299940?name=298&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "ORPHA:254827 Mitochondrial membrane transport disorder\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:02:43.439007",
  "run_number": 1,
  "total_drugs_found": 9,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Mitochondrial+neurogastrointestinal+encephalomyopathy&orphaCode=298&name=298&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Mitochondrial neurogastrointestinal encephalomyopathy",
    "orphaCode": "298",
    "name": "298",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}